NCT Number: NCT01054690
Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)
This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Ortopedkliniken, Hässleholms Sjukhus, Hässleholm, Sweden
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adults in elective surgery requiring urinary catheterization
Exclusion criteria
- Patients who has or recently (within 3 weeks) had a urinary catheter
- Signs of urinary tracts infection
- Previous radiation therapy in lower pelvis
- Latex allergy
- Cognitive impaired
- Do not understand Swedish language.
Treatment and study plan
Silicone Urinary Catheter
DevicePrimary outcomes
-
To determine whether a silver alloyed catheter with antibacterial properties will decrease the incidence of catheter associated urinary tract infection in patients undergoing elective surgery.
Time frame: At catheter withdrawal (normally 1-3 days after catheter insertion).
Secondary outcomes
-
Patient´s evaluation of the catheterization and overall satisfaction.
Time frame: At catheter withdrawal and 7-10 days after catheter withdrawal.
Sponsors and collaborators
Lead sponsor
Region Skane
Other
Collaborators
- Bactiguard AB, Sweden
Registry information
Official study title
A Comparative Study to Investigate if Silver Alloyed Urinary Catheters Can Reduce the Incidence of Catheter Acquired Urinary Tract Infections in Patients Undergoing Elective Surgery
Important dates
- Study start
- 2008
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Jan 22, 2010
- Registry last updated
- Jan 22, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
NCT06059846
Acute Pyelonephritis, Female Urogenital Diseases
Miami, Florida, United States
View Trial DetailsSafety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
NCT01388413
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Garches, France
View Trial DetailsNettle and Cranberry Capsules for Prevention of Urinary Tract Infection
NCT05880602
Disease Attributes, Female Urogenital Diseases
Taichung, Taiwan
View Trial DetailsProphylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
NCT04502095
Bladder Carcinoma, Female Urogenital Diseases
Buffalo, New York, United States
View Trial Details